Molecular and Cellular Biology Laboratory, National Institute for Research in Reproductive Health, Indian Council of Medical Research, J.M. Street, Parel, Mumbai, Maharashtra, India.
J Assist Reprod Genet. 2013 Mar;30(3):413-22. doi: 10.1007/s10815-013-9933-0. Epub 2013 Jan 24.
Yq microdeletions are the leading genetic cause of male infertility and its detection is clinically relevant for appropriate genetic counseling. We aimed to determine the prevalence and type of Yq microdeletions, the associated seminal phenotypes and the STS markers that are relevant for its testing in Indian population.
Yq microdeletion analysis was carried out in 1,636 infertile cases in our centers. Additional data was collected from published studies in Indian population leading to a total of 3,647 cases.
In our cohort, 3.4 % (56/1,636) of infertile men had Yq microdeletions. Combining the data from other published studies identified 215/3,647 (5.8 %) infertile individuals to harbor Yq microdeletions; with 6.4 % in azoopsermia, 5.8 % in oligozoospermia and 3.2 % in oligoasthenozoospermia and teratozoospermia cases. No significant differences in the deletion frequencies were observed between idiopathic vs non idiopathic cases (5.8 vs 8.6 % respectively). Deletions of AZFc were at highest frequency (46.6 %) with double deletions most commonly observed in azoospermic subjects. With respect to the STS markers, screening with the six European Academy of Andrology (EAA) markers would miss 3.1 % of cases; additional non EAA markers that would contribute significantly to screening are sY746, sY82, sY121, sY128, sY130, sY143, sY145 & sY160.
The frequency of Yq microdeletions is lower in Indian population as compared to Western counterparts. There is no major association of Yq microdeletions with seminal parameters or cause of infertility. Clinically it will be necessary to offer Yq microdeletion testing to all the classes of infertile men. The EAA markers may not be adequate to detect microdeletions in Indian infertile men.
Y 染色体微缺失是男性不育的主要遗传原因,其检测对于适当的遗传咨询具有临床意义。我们旨在确定 Y 染色体微缺失的流行率和类型、相关的精液表型以及进行检测的 STS 标记,这些标记在印度人群中具有相关性。
在我们的中心对 1636 例不育病例进行了 Y 染色体微缺失分析。从印度人群发表的研究中收集了额外的数据,总计 3647 例。
在我们的队列中,3.4%(56/1636)的不育男性存在 Y 染色体微缺失。结合其他发表的研究数据,确定 3647 例不育个体中有 215 例(5.8%)存在 Y 染色体微缺失;其中无精子症占 6.4%,少精子症占 5.8%,少弱精子症和畸形精子症分别占 3.2%。在特发性与非特发性病例之间,缺失频率无显著差异(分别为 5.8%和 8.6%)。AZFc 缺失频率最高(46.6%),双缺失最常见于无精子症患者。就 STS 标记而言,用欧洲男科协会(EAA)的 6 个标记进行筛查会漏诊 3.1%的病例;额外的非 EAA 标记,如 sY746、sY82、sY121、sY128、sY130、sY143、sY145 和 sY160,将显著有助于筛查。
与西方人群相比,印度人群的 Y 染色体微缺失频率较低。Y 染色体微缺失与精液参数或不育原因之间没有主要关联。临床上,有必要对所有类型的不育男性进行 Y 染色体微缺失检测。EAA 标记可能不足以检测印度不育男性的微缺失。